483
Enemeez, LLC dba Summit PharmaceuticalsEnemeez, LLC dba Summit Pharmaceuticals – FDA 483, Feb 12, 2026
Record Details
Eneemez LLC, a manufacturer in Phoenix, AZ, was inspected and received a Form 483 with five observations indicating significant deficiencies in its quality control unit and manufacturing processes. The observations highlight failures in quality oversight, inadequate investigations, improper product testing, deficient raw material testing, and incomplete cleaning validations, suggesting a moderate to severe level of non-compliance with cGMP regulations.
- Office
- Denver District Office
- Person
View Company Profile
ID · c99c982e-dc97-4c4a-b6e1-05056ce42a24
Other documents for Enemeez, LLC dba Summit Pharmaceuticals
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.